Enriched
A unit dosage of an oral composition of an extract of Withania somnifera is disclosed. The extract of Withania somnifera includes total withanolides. The total withanolides includes withanolide glycosides and withanolide aglycones. The extract of Withania somnifera includes about 32% to about 38% by weight of the withanolide glycosides. Methods of preparing the extract of Withania somnifera are disclosed. Methods of treatment by administering the extract of Withania somnifera are disclosed.
1 . A unit dosage of an oral composition of an extract of Withania somnifera , wherein the extract of Withania somnifera comprises total withanolides, wherein the total withanolides comprise withanoilide glycosides and withanolide aglycones, wherein the extract of Withania somnifera comprises about 32% to about 38% by weight of the withanolide glycosides, wherein the withanolide glycosides comprise withanoside IV, and the withanolide aglycones comprise withanolide A and withaferin A, wherein the extract of Withania somnifera comprises a ratio of withanoside IV: withaferin A is in a range of about 1:3 w/w to about 3:1 w/w, wherein a dosage form comprising the unit dosage of the oral composition of the extract of Withania somnifera is selected from a group comprising capsule, tablet powder, granule, soft gel capsule, suspension, dispersion, elixir, paste, gel, liquid, dragees, and combinations thereof, and wherein a dosage of the extract of Withania somnifera in the unit dosage of the oral composition of the extract of Withania somnifera ranges from about 1 mg to about 1000 mg of the extract of Withania somnifera .
2 . The unit dosage of the oral composition of the extract of Withania somnifera of claim 1 further comprising an additive, wherein the additive is selected from the group consisting of a nutrient, magnesium stearate, stearic acid, rice flour, cellulose, silicon dioxide, sugar, hydroxypropyl methylcellulose, glycerine, gelatine, propylene glycol, polyethylene glycol, pectin, sodium citrate, beeswax, purified water, vegetable oil, injectable organic esters and combinations thereof.
3 . The unit dosage of the oral composition of the extract of Withania somnifera of claim 1 , wherein the extract of Withania somnifera comprises about 35% by weight of the withanolide glycosides.
4 . The unit dosage of the oral composition of the extract of Withania somnifera of claim 1 , wherein the extract of Withania somnifera comprises at least about 2% withanoside IV by weight and about 2% withaferin A by weight.
5 . The unit dosage of the oral composition of the extract of Withania somnifera of claim 1 , wherein the extract of Withania somnifera is prepared from the root and leaf of Withania somnifera plant.
6 . The unit dosage of the oral composition of the extract of Withania somnifera of claim 2 , wherein the nutrient is selected from a group consisting of amino acids, carbohydrates, vitamins, folic acid, omega-3 fatty acids, minerals, herbal extracts, lutein, zeaxanthin, antioxidants and combination thereof.
7 . The unit dosage of the oral composition of the extract of Withania somnifera of claim 1 comprising a dosage ranging from about 24 mg to about 480 mg of the extract of Withania somnifera.
8 . The unit dosage of the oral composition of claim 1 , wherein an effective dose ranges from about 0.4 mg to about 8 mg of the extract of Withania somnifera per kg body weight of a mammal.